Legacy Wealth Asset Management LLC Cuts Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Legacy Wealth Asset Management LLC lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 12.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 140,837 shares of the company’s stock after selling 20,779 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Takeda Pharmaceutical were worth $1,865,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in TAK. Public Employees Retirement System of Ohio bought a new position in Takeda Pharmaceutical in the 3rd quarter valued at $601,000. Verition Fund Management LLC bought a new position in Takeda Pharmaceutical during the third quarter valued at about $1,533,000. HighTower Advisors LLC increased its holdings in Takeda Pharmaceutical by 199.5% during the third quarter. HighTower Advisors LLC now owns 122,587 shares of the company’s stock worth $1,744,000 after buying an additional 81,653 shares during the last quarter. XTX Topco Ltd bought a new stake in Takeda Pharmaceutical in the third quarter worth about $957,000. Finally, Creative Planning boosted its stake in Takeda Pharmaceutical by 46.3% in the third quarter. Creative Planning now owns 157,630 shares of the company’s stock valued at $2,242,000 after acquiring an additional 49,871 shares during the last quarter. 9.17% of the stock is owned by institutional investors.

Takeda Pharmaceutical Stock Down 0.4 %

Takeda Pharmaceutical stock opened at $13.05 on Friday. The company has a quick ratio of 0.77, a current ratio of 1.28 and a debt-to-equity ratio of 0.64. The company has a market capitalization of $41.51 billion, a P/E ratio of 22.49, a P/E/G ratio of 0.23 and a beta of 0.51. The firm has a 50 day moving average price of $13.40 and a 200-day moving average price of $13.89. Takeda Pharmaceutical Company Limited has a twelve month low of $12.57 and a twelve month high of $15.08.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.